Oxytocin for Hypermobile Ehlers-Danlos Syndrome
Clinical trial NCT05405257 · TERMINATED
Trial details
- NCT number
- NCT05405257
- Sponsor
- Baylor College of Medicine
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-13
- Primary completion
- 2025-03-11
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.